← Evidence map

ArticleCancer pathogenesis and therapy2025

Efficacy and safety of camrelizumab plus

Tengfei Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

2 papers cite it

2025
2026
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 40697510